Recombinant Human PRTN3 Protein，His & Myc

PRTN3 (Proteinase 3) is a serine protease that plays a significant role in various physiological and pathological processes, particularly in the immune system and inflammatory responses. It is predominantly expressed in neutrophils and is thought to be involved in the proteolytic activation of pro-inflammatory cytokines and in the defense against microbial infections. Dysregulation of PRTN3 has been implicated in several diseases, including autoimmune disorders, where it can contribute to inflammation and tissue damage. Moreover, PRTN3 has garnered attention for its association with anti-neutrophil cytoplasmic antibodies (ANCA) in vasculitis, a class of autoimmune diseases characterized by inflammation of blood vessels. Recent research has focused on elucidating the molecular mechanisms underlying PRTN3's functions, exploring its potential as a biomarker for disease diagnosis, and investigating its role as a therapeutic target. The ability to produce recombinant PRTN3 has facilitated studies on its structure, function, and interactions with other proteins, thus providing insights into its regulatory roles in immune responses and its potential implications in drug development for inflammatory diseases. Understanding the multifaceted roles of PRTN3 will not only enhance the knowledge of immune regulation but may also lead to innovative therapeutic strategies for diseases where PRTN3 is involved.